drugset

drugset / Trial / NCT01650415

Erythropoietin Therapy for Children With Cerebral Palsy

NCT01650415 ↗

Phase 2 Completed 11 enrolled Bundang CHA Hospital LG Life Sciences · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized placebo-controlled trial aims to investigate the efficacy and safety of erythropoetin for children with cerebral palsy.

Timeline

Start: 2014-09
Primary completion: 2015-02
Completion: 2015-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	epoetin alfa	Protein / enzyme biologic	—	—

Indications